Refractory Anemia With Ring Sideroblasts: Clinical Trials

1 trial for Refractory Anemia With Ring Sideroblasts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Refractory Anemia With Ring Sideroblasts: new trials by email Literature Review of Refractory Anemia With Ring Sideroblasts trials Research Report on Refractory Anemia With Ring Sideroblasts

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome
Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1TerminatedFred Hutchinson Cancer Center262007-10-052023-02-09

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Myelodysplastic Syndromes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cyclophosphamide (1)  ·  Iodine-131 (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Fred Hutchinson Cancer Center (1)

Countries

United States (1)

Top investigators

Johnnie Orozco (1)

Results publications

PMID 37939122

NIH funding

P01CA044991 (1)